Suzanne McLeod is a graduate of Austin Peay State University and began her work in the generic pharmaceutical industry in 2008. Suzanne is currently a Manager of REMS for Hikma Pharmaceuticals USA Inc. She has been involved in building and implementing shared REMS programs since 2009 as a member of the original IWG for the Extended Release/Long Acting Opioid that was approved in 2012. She is the FDA Liaison for several approved shared REMS programs and is an active participant at the subteam level for the shared programs she manages for Hikma, including the Opioid Analgesic REMS Program, BTOD REMS Program, Alosetron REMS Program, and Bosentan REMS Program.